Acute myocardial infarction and drug-eluting stents: A green light for their use or time for measured restraint?
Open Access
- 31 May 2007
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 153 (5) , 719-721
- https://doi.org/10.1016/j.ahj.2007.02.017
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarctionAmerican Heart Journal, 2007
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsPublished by Elsevier ,2006
- Trading Restenosis for Thrombosis? New Questions about Drug-Eluting StentsNew England Journal of Medicine, 2006
- Acute Coronary Syndrome May Occur With In-Stent Restenosis and Is Associated With Adverse Outcomes (The PRESTO Trial)The American Journal of Cardiology, 2006
- Bare metal stent restenosis is not a benign clinical entityPublished by Elsevier ,2006
- On- Versus Off-Label Use of Drug-Eluting Coronary Stents in Clinical Practice (Report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])The American Journal of Cardiology, 2006
- Myocardial Infarction as a Presentation of Clinical In-Stent RestenosisCirculation Journal, 2006
- Frequency, Predictors, and Outcomes of Drug-Eluting Stent Utilization in Patients With High-Risk Non–ST-Segment Elevation Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Drug-eluting stent thrombosisJournal of the American College of Cardiology, 2005
- A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stentsThe Lancet, 2004